Bioconjugation Insights is an online, open access, peer-reviewed journal with an interdisciplinary, translational focus on all aspects and areas of the bioconjugation field, including ADCs, oligonucleotide conjugates, protein and peptide conjugates, PEGylation, radioconjugates, conjugated vaccines, diagnostics, and more.
Bioconjugation Insights is designed to provide the understanding and need-to-know information required to navigate this rapidly advancing sector. It serves as the go-to online resource for the latest news, trends, challenges, and breakthroughs in bioconjugation. You can find more information about our aims and scope here
Sign-up for free for unlimited access to all of our articles, webinars, podcasts, news, interviews, and more.
April 2025
Volume 1 Issue 1
Welcome to the inaugural issue of Bioconjugation Insights!
Although bioconjugation has been featured across our other BioInsights publications, we have recognized the need for a dedicated platform that captures the full breadth, complexity, and rapidly evolving nature of this field. The journal aims to bring together experts from across the bioconjugation landscape, offering readers the latest insights and developments.
We extend our sincere thanks to our Editorial Advisory Board and all those who have contributed their time, perspectives, and expertise.
We hope you enjoy this inaugural edition of Bioconjugation Insights—and that it becomes your go-to resource as this vital field continues to grow and evolve.
Spotlight: Launch Edition
Latest Articles
Welcome to Bioconjugation Insights
Addressing the shortfalls of LNP-based delivery with conjugate modalities
Industry insights, April 2025
Translating research into therapeutics: the future of ADCs in cancer therapy
Harnessing peptide conjugates strategies for cancer immunotherapy and infectious disease
Next-generation conjugates: small peptides to transform targeted cancer therapy
Striking a balance between ADC safety and efficacy
Chemical modifications for therapeutic aptamers
